Abstract
An agar dilution method was employed to test the susceptibility of 12 strains of Coccidioides immitis to polymyxin B (PB). After 3 days of incubation, eight strains were markedly inhibited by 5.0 μg of PB per ml and four strains did not grow. PB at 10 μg/ml inhibited the growth of all strains through 20 days of incubation. To determine whether PB has anticoccidioidal activity in vivo, mice in groups of 30 were infected intraperitoneally with a mean lethal dose (LD50) or 20 LD50 of arthrospores of C. immitis ATCC 28868 (Silveira). Treatment by intraperitoneal injection of PB (2.5 mg/kg) was begun 2 or 5 days after challenge. By 40 days after infection, 47 and 7% of the untreated mice challenged with an LD50, respectively, were alive. Of mice infected with an LD50 or 20 LD50 and treated with PB beginning 2 days after the challenge, 90% of each group were alive by day 40. Initiation of PB therapy 5 days after infection permitted survival of 84% of the mice infected with an LD50; however, only 27% of the mice infected with 20 LD50 survived by day 40. In this latter group there was evidence that PB prolonged life since 56% of the treated mice were alive by day 15 as compared with 30% of the controls. PB in vivo was fungistatic since the majority of treated mice had C. immitis in the liver, lungs, and spleen.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bryant R. E., Hammond D. Interaction of purulent material with antibiotics used to treat Pseudomonas infections. Antimicrob Agents Chemother. 1974 Dec;6(6):702–707. doi: 10.1128/aac.6.6.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Collins M. S. Inhibition of growth of Coccidioides immitis on Sabouraud medium containing polymyxin B. J Clin Microbiol. 1975 Mar;1(3):335–336. doi: 10.1128/jcm.1.3.335-336.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Collins S., Pappagians D. Inhibition of Coccidioides immitis in vitro and enhancement of antiococcidiodial effects of amphotericin B by polymyxin B. Antimicrob Agents Chemother. 1975 Jun;7(6):781–787. doi: 10.1128/aac.7.6.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Furey W., Ciric I., Parker R. H. Monitoring of intrathecal polymyxin B dosage during treatment of pseudomonas meningitis. IMJ Ill Med J. 1971 May;139(5):506–510. [PubMed] [Google Scholar]
- Geelhoed G. W., Ketcham A. S. Pseudomonas meningitis complicating radical resection for radiorecurrent cancer of the paranasal sinuses: report of two patients successfully treated with intrathecal polymyxin. J Surg Oncol. 1973;5(4):365–374. doi: 10.1002/jso.2930050412. [DOI] [PubMed] [Google Scholar]
- Kong Y. M., Savage D. C., Levine H. B. Enhancement of immune responses in mice by a booster injection of Coccidioides spherules. J Immunol. 1965 Dec;95(6):1048–1056. [PubMed] [Google Scholar]
- Kunin C. M., Bugg A. Binding of polymyxin antibiotics to tissues: the major determinant of distribution and persistence in the body. J Infect Dis. 1971 Oct;124(4):394–400. doi: 10.1093/infdis/124.4.394. [DOI] [PubMed] [Google Scholar]
- Savage D. C., Madin S. H. Cellular responses in lungs of immunized mice to intranasal infection with Coccidioides immitis. Sabouraudia. 1968 Feb;6(2):94–102. doi: 10.1080/00362176885190181. [DOI] [PubMed] [Google Scholar]
- Sinski J. T., Soto P. J., Jr Onset of coccidioidomycosis in mouse lung after intravenous injection. Mycopathol Mycol Appl. 1966 Oct 4;30(1):41–46. doi: 10.1007/BF02051707. [DOI] [PubMed] [Google Scholar]
- TARBET J. E., WRIGHT E. T., NEWCOMER V. D. Experimental coccidioidal granuloma; developmental stages of sporangia in mice. Am J Pathol. 1952 Sep-Oct;28(5):901–917. [PMC free article] [PubMed] [Google Scholar]